| Senolytic CAR T cells reverse senescence-associated pathologies C Amor, J Feucht, J Leibold, YJ Ho, C Zhu, D Alonso-Curbelo, ... Nature 583 (7814), 127-132, 2020 | 686 | 2020 |
| NK cell–mediated cytotoxicity contributes to tumor control by a cytostatic drug combination M Ruscetti, J Leibold, MJ Bott, M Fennell, A Kulick, NR Salgado, CC Chen, ... Science 362 (6421), 1416-1422, 2018 | 321 | 2018 |
| Senescence-induced vascular remodeling creates therapeutic vulnerabilities in pancreas cancer M Ruscetti, JP Morris, R Mezzadra, J Russell, J Leibold, PB Romesser, ... Cell 181 (2), 424-441. e21, 2020 | 281 | 2020 |
| Resistance to TRK inhibition mediated by convergent MAPK pathway activation E Cocco, AM Schram, A Kulick, S Misale, HH Won, R Yaeger, P Razavi, ... Nature medicine 25 (9), 1422-1427, 2019 | 187 | 2019 |
| SFK/FAK signaling attenuates osimertinib efficacy in both drug-sensitive and drug-resistant models of EGFR-mutant lung cancer E Ichihara, D Westover, CB Meador, Y Yan, JA Bauer, P Lu, F Ye, A Kulick, ... Cancer research 77 (11), 2990-3000, 2017 | 131 | 2017 |
| HER2+ breast cancers evade anti-HER2 therapy via a switch in driver pathway AE Smith, E Ferraro, A Safonov, CB Morales, EJA Lahuerta, Q Li, A Kulick, ... Nature Communications 12 (1), 6667, 2021 | 61 | 2021 |
| Senescence induction dictates response to chemo-and immunotherapy in preclinical models of ovarian cancer SV Paffenholz, C Salvagno, YJ Ho, M Limjoco, T Baslan, S Tian, A Kulick, ... Proceedings of the National Academy of Sciences 119 (5), e2117754119, 2022 | 55 | 2022 |
| Establishing and maintaining an extensive library of patient-derived xenograft models M Mattar, CR McCarthy, AR Kulick, B Qeriqi, S Guzman, E De Stanchina Frontiers in oncology 8, 19, 2018 | 53 | 2018 |
| The ectonucleotidase CD39 identifies tumor-reactive CD8+ T cells predictive of immune checkpoint blockade efficacy in human lung cancer A Chow, FZ Uddin, M Liu, A Dobrin, BY Nabet, L Mangarin, Y Lavin, ... Immunity 56 (1), 93-106. e6, 2023 | 48 | 2023 |
| Somatic tissue engineering in mouse models reveals an actionable role for WNT pathway alterations in prostate cancer metastasis J Leibold, M Ruscetti, Z Cao, YJ Ho, T Baslan, M Zou, W Abida, J Feucht, ... Cancer discovery 10 (7), 1038-1057, 2020 | 46 | 2020 |
| TRK xDFG mutations trigger a sensitivity switch from type I to II kinase inhibitors E Cocco, JE Lee, S Kannan, AM Schram, HH Won, S Shifman, A Kulick, ... Cancer discovery 11 (1), 126-141, 2021 | 44 | 2021 |
| EZH2 inhibition remodels the inflammatory senescence-associated secretory phenotype to potentiate pancreatic cancer immune surveillance L Chibaya, KC Murphy, KD DeMarco, S Gopalan, H Liu, CN Parikh, ... Nature cancer 4 (6), 872-892, 2023 | 32 | 2023 |
| Genomic and transcriptomic analysis of a library of small cell lung cancer patient-derived xenografts R Caeser, JV Egger, S Chavan, ND Socci, CB Jones, FE Kombak, ... Nature Communications 13 (1), 2144, 2022 | 32 | 2022 |
| In Vitro Selection of a Single‐Stranded DNA Molecular Recognition Element Specific for Bromacil RM Williams, AR Kulick, S Yedlapalli, L Battistella, CJ Hajiran, LJ Sooter Journal of Nucleic Acids 2014 (1), 102968, 2014 | 26 | 2014 |
| CryoPause: a new method to immediately initiate experiments after cryopreservation of pluripotent stem cells KG Wong, SD Ryan, K Ramnarine, SA Rosen, SE Mann, A Kulick, ... Stem cell reports 9 (1), 355-365, 2017 | 22 | 2017 |
| Senescence-induced vascular remodeling creates therapeutic vulnerabilities in pancreas cancer M Ruscetti, JP Morris, R Mezzadra, J Russell, J Leibold, PB Romesser, ... Cell 184 (18), 4838-4839, 2021 | 20 | 2021 |
| Predicting gemcitabine delivery by 18F-FAC PET in murine models of pancreatic cancer J Russell, M Grkovski, IJ O’Donoghue, TM Kalidindi, N Pillarsetty, ... Journal of Nuclear Medicine 62 (2), 195-200, 2021 | 6 | 2021 |
| Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer (vol 181, pg 424, 2020) M Ruscetti, JP Morris, R Mezzadra, J Russell, J Leibold, PB Romesser, ... Cell 184 (18), 4838-4839, 2021 | 3 | 2021 |
| A Druggable FOXA1-Glucocorticoid Receptor Transcriptional Axis Drives Tumor Growth in a Subset of Non-Small Cell Lung Cancer M Dorso, PT Patel, A Pankov, JA Boyer, RK Soni, IS Del Priore, O Hayatt, ... Cancer Research Communications 3 (9), 1788-1799, 2023 | 2 | 2023 |
| CD39 identifies tumor-reactive CD8 T cells in patients with lung cancer A Chow, FZ Uddin, L Mangarin, H Rizvi, A Dobrin, S Tischfield, ... | 2 | 2022 |
